Insights
Search Results
Client Highlights
2.24.26
Wilson Sonsini Advises Profound on $96 Million Series C at a $1 Billion Valuation
On February 24, 2026, Profound, a marketing platform for the AI-era, announced it raised a $96 million Series C at a $1 billion valuation led by Lightspeed Venture Partners. Existing investors Sequoia Capital, Kleiner Perkins, Saga VC, South Park Commons, and Evantic joined the round. Wilson Sonsini Goodrich & Rosati advised Profound on the transaction.
Client Highlights
3.31.23
Wilson Sonsini Advises VirnetX on Dividend and Shareholder Agreement
On March 30, 2023, internet security company VirnetX announced a special cash dividend of $1.00 per share, as well as a cooperation agreement with shareholders Bradley L. Radoff and Michael Torok. Wilson Sonsini Goodrich & Rosati advised VirnetX on the transactions.
Client Highlights
3.14.23
Wilson Sonsini Advises Switch on $52 Million Financing and Launch
On March 14, 2023, Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use RNA science to treat diseases, announced its launch following $52 million of financing. The company’s Series A was co-led by Insight Partners and UCB Ventures. Existing investors Upfront Ventures and BOLD Capital Partners and new investors Eli Lilly and Company, Ono Venture Investment, Digitalis Ventures, Dolby Family Ventures, Free Flow Ventures, PhiFund Ventures, and others also participated in the financing. Wilson Sonsini Goodrich & Rosati advised Switch Therapeutics on the transaction and launch.